Drugs / Sodium Sulfate
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | OCL | — | 1986-04-30 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT06317597 Comparator | Mar → Dec 2024 | — | Changhai Hospital | Unknown | No outcome recorded |
| — | NCT06949176 Background | Dec 2023 → Dec 2024 overdue | periapical periodontitis | National and Kapodistrian University of Athens | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Sulfate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06949176 ↗ |